Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 4
2014 1
2015 4
2016 3
2017 5
2018 5
2019 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.
Saiz-Rodríguez M, Belmonte C, Román M, Ochoa D, Koller D, Talegón M, Ovejero-Benito MC, López-Rodríguez R, Cabaleiro T, Abad-Santos F. Saiz-Rodríguez M, et al. Among authors: talegon m. Basic Clin Pharmacol Toxicol. 2018 May;122(5):501-511. doi: 10.1111/bcpt.12938. Epub 2017 Dec 13. Basic Clin Pharmacol Toxicol. 2018. PMID: 29136336 Free article. Clinical Trial.
Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis.
Prieto-Pérez R, Llamas-Velasco M, Cabaleiro T, Solano-López G, Márquez B, Román M, Ochoa D, Talegón M, Daudén E, Abad-Santos F. Prieto-Pérez R, et al. Among authors: talegon m. Pharmacogenomics. 2017 Jan;18(2):157-164. doi: 10.2217/pgs-2016-0122. Epub 2016 Dec 15. Pharmacogenomics. 2017. PMID: 27977334
Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis.
Ovejero-Benito MC, Prieto-Pérez R, Llamas-Velasco M, Belmonte C, Cabaleiro T, Román M, Ochoa D, Talegón M, Saiz-Rodríguez M, Daudén E, Abad-Santos F. Ovejero-Benito MC, et al. Among authors: talegon m. Pharmacogenomics. 2017 May;18(7):631-638. doi: 10.2217/pgs-2017-0014. Epub 2017 May 4. Pharmacogenomics. 2017. PMID: 28470127
Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.
Ovejero-Benito MC, Prieto-Pérez R, Llamas-Velasco M, Muñoz-Aceituno E, Reolid A, Saiz-Rodríguez M, Belmonte C, Román M, Ochoa D, Talegón M, Cabaleiro T, Daudén E, Abad-Santos F. Ovejero-Benito MC, et al. Among authors: talegon m. Pharmacogenomics. 2018 Jan;19(1):7-16. doi: 10.2217/pgs-2017-0143. Epub 2017 Dec 1. Pharmacogenomics. 2018. PMID: 29192552 Free article.
Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis.
Ovejero-Benito MC, Cabaleiro T, Sanz-García A, Llamas-Velasco M, Saiz-Rodríguez M, Prieto-Pérez R, Talegón M, Román M, Ochoa D, Reolid A, Daudén E, Abad-Santos F. Ovejero-Benito MC, et al. Among authors: talegon m. Br J Dermatol. 2018 Mar;178(3):798-800. doi: 10.1111/bjd.15504. Epub 2018 Jan 28. Br J Dermatol. 2018. PMID: 28369750 No abstract available.
New polymorphisms associated with response to anti-TNF drugs in patients with moderate-to-severe plaque psoriasis.
Prieto-Pérez R, Solano-López G, Cabaleiro T, Román M, Ochoa D, Talegón M, Baniandrés O, López-Estebaranz JL, de la Cueva P, Daudén E, Abad-Santos F. Prieto-Pérez R, et al. Among authors: talegon m. Pharmacogenomics J. 2018 Jan;18(1):70-75. doi: 10.1038/tpj.2016.64. Epub 2016 Sep 27. Pharmacogenomics J. 2018. PMID: 27670765 Free article.
18 results